Journal for ImmunoTherapy of Cancer (Nov 2023)

645 A phase 1B/2, open-label study of Q702 in combination with intravenous pembrolizumab in patients with selected advanced solid tumors

  • Do-Youn Oh,
  • Seung-Tae Kim,
  • Sun Young Rha,
  • Anthony El-Khoueiry,
  • Hong Jae Chon,
  • Jaspreet Grewal,
  • Jeongjun Kim,
  • Hyunji Ahn,
  • Jinho Choi,
  • Seung-Hee Ryu,
  • Jiye Ahn,
  • Bae Jung Choi,
  • Hwankyu Kang,
  • Yeong-In Yang,
  • Seung-Joo Lee,
  • Borami Jeon,
  • Stefan Proniuk,
  • Kiyean Nam,
  • Baek-Yeol Ryoo

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0645
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.